Search Results - "Yi, Long"

Laser Fabrication of Graphene‐Based Flexible Electronics by You, Rui, Liu, Yu‐Qing, Hao, Yi‐Long, Han, Dong‐Dong, Zhang, Yong‐Lai, You, Zheng

“…Recent years have witnessed the rise of graphene and its applications in various electronic devices. Specifically, featuring excellent flexibility,…”
Get full text

Biological Nanopores: Confined Spaces for Electrochemical Single-Molecule Analysis by Cao, Chan, Long, Yi-Tao

“…Conspectus Nanopore sensing is developing into a powerful single-molecule approach to investigate the features of biomolecules that are not accessible by…”
Get full text

Confined Nanopipette Sensing: From Single Molecules, Single Nanoparticles, to Single Cells by Yu, Ru‐Jia, Ying, Yi‐Lun, Gao, Rui, Long, Yi‐Tao

“…Nanopipettes provide a promising confined space that enables advances in electrochemical, optical, and mass spectrometric measurements at the nanoscale. They…”
Get full text

Lung cancer: current therapies and new targeted treatments by Hirsch, Fred R, Prof, Scagliotti, Giorgio V, Prof, Mulshine, James L, Prof, Kwon, Regina, BA, Curran, Walter J, Prof, Wu, Yi-Long, Prof, Paz-Ares, Luis, Prof

“…Summary Lung cancer is the most frequent cause of cancer-related deaths worldwide. Every year, 1·8 million people are diagnosed with lung cancer, and 1·6…”
Get full text

Unveiling the Intrinsic Catalytic Activities of Single‐Gold‐Nanoparticle‐Based Enzyme Mimetics by Hafez, Mahmoud Elsayed, Ma, Hui, Ma, Wei, Long, Yi‐Tao

“…Gold nanoparticles (AuNPs) have been demonstrated to serve as effective nanomaterial‐based enzyme mimetics (nanozymes) for a number of enzymatic reactions…”
Get full text

Nanopore-Based Single-Biomolecule Interfaces: From Information to Knowledge by Ying, Yi-Lun, Long, Yi-Tao

“…Single-molecule measurements have greatly enhanced our understanding of living systems. Biological systems offer nanopores, a sub-class of membrane proteins,…”
Get full text

Biological Nanopore Approach for Single‐Molecule Protein Sequencing by Hu, Zheng‐Li, Huo, Ming‐Zhu, Ying, Yi‐Lun, Long, Yi‐Tao

“…Proteins are responsible for the occurrence and treatment of many diseases, and therefore protein sequencing will revolutionize proteomics and clinical…”
Get full text

Hydrothermal Synthesis of VO2 Polymorphs: Advantages, Challenges and Prospects for the Application of Energy Efficient Smart Windows by Li, Ming, Magdassi, Shlomo, Gao, Yanfeng, Long, Yi

“…Vanadium dioxide (VO2) is a widely studied inorganic phase change material, which has a reversible phase transition from semiconducting monoclinic to metallic…”
Get full text

Black Phosphorus Nanosheets: Synthesis, Characterization and Applications by Eswaraiah, Varrla, Zeng, Qingsheng, Long, Yi, Liu, Zheng

“…Black phosphorus (BP) is an emerging two‐dimensional (2D) material with a natural bandgap, which has unique anisotropy and extraordinary physical properties…”
Get full text

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer by Solomon, Benjamin J, Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Tursi, Jennifer, Blackhall, Fiona

“…The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater…”
Get full text

Dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice by Gong, Shuai, Miao, Yi-Long, Jiao, Guang-Zhong, Sun, Ming-Ju, Li, Hong, Lin, Juan, Luo, Ming-Jiu, Tan, Jing-He

“…Although plasma corticosterone is considered the main glucocorticoid involved in regulation of stress responses in rodents, the presence of plasma cortisol and…”
Get full text

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial by Wu, Yi-Long, Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Tsuji, Fumito, Linke, Rolf, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Sbar, Eric I, Wang, Tao, White, Jane Liang, Nadanaciva, Sashi, Sandin, Rickard, Mok, Tony S

“…Dacomitinib is a second-generation, irreversible EGFR tyrosine kinase inhibitor. We compared its efficacy and safety with that of the reversible EGFR tyrosine…”
Get full text

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC by Tsuboi, Masahiro, Herbst, Roy S., John, Thomas, Kato, Terufumi, Majem, Margarita, Grohé, Christian, Wang, Jie, Goldman, Jonathan W., Lu, Shun, Su, Wu-Chou, de Marinis, Filippo, Shepherd, Frances A., Lee, Ki Hyeong, Le, Nhieu Thi, Dechaphunkul, Arunee, Kowalski, Dariusz, Poole, Lynne, Bolanos, Ana, Rukazenkov, Yuri, Wu, Yi-Long

“…Patients with resected, EGFR -mutated, stage IB to IIIA NSCLC were randomly assigned to receive adjuvant osimertinib or placebo for 3 years. The 5-year overall…”
Get full text

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer by Wu, Yi-Long, Tsuboi, Masahiro, He, Jie, John, Thomas, Grohe, Christian, Majem, Margarita, Goldman, Jonathan W, Laktionov, Konstantin, Kim, Sang-We, Kato, Terufumi, Vu, Huu-Vinh, Lu, Shun, Lee, Kye-Young, Akewanlop, Charuwan, Yu, Chong-Jen, de Marinis, Filippo, Bonanno, Laura, Domine, Manuel, Shepherd, Frances A, Zeng, Lingmin, Hodge, Rachel, Atasoy, Ajlan, Rukazenkov, Yuri, Herbst, Roy S

“…The incidence of recurrence after curative resection among patients with stage IB, II, or IIIA non–small-cell lung cancer is high and is only slightly lower…”
Get full text

Combination Therapy for EGFR -Mutated Lung Cancer by Wu, Yi-Long, Zhou, Qing

“…Targeted therapy has improved prognoses for patients with advanced non–small-cell lung cancer (NSCLC) that has epidermal growth factor receptor (EGFR)…”
Get full text

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China Study by Wu, Yi‐Long, Zhang, Li, Fan, Yun, Zhou, JianYing, Zhang, Li, Zhou, Qing, Li, Wei, Hu, ChengPing, Chen, GongYan, Zhang, Xin, Zhou, CaiCun, Dang, Thao, Sadowski, Sara, Kush, Debra A., Zhou, Yu, Li, Ben, Mok, Tony

“…In the global KEYNOTE‐042 study (Clinicaltrials.gov, NCT02220894), pembrolizumab significantly improved overall survival (OS) vs chemotherapy in patients with…”
Get full text

Emerging therapies for non-small cell lung cancer by Zhang, Chao, Leighl, Natasha B, Wu, Yi-Long, Zhong, Wen-Zhao

“…Recent advances in the field of novel anticancer agents prolong patients' survival and show a promising future. Tyrosine kinase inhibitors and immunotherapy…”
Get full text

Efficient Passivation of Hybrid Perovskite Solar Cells Using Organic Dyes with COOH Functional Group by Li, Xing, Chen, Chun‐Chao, Cai, Molang, Hua, Xin, Xie, Fengxian, Liu, Xiao, Hua, Jianli, Long, Yi‐Tao, Tian, He, Han, Liyuan

“…Organic–inorganic halide perovskites are efficient absorbers for solar cells. Nevertheless, the trap states at the surfaces and grain boundaries are a…”
Get full text

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma by Dong, Zhong-Yi, Zhong, Wen-Zhao, Zhang, Xu-Chao, Su, Jian, Xie, Zhi, Liu, Si-Yang, Tu, Hai-Yan, Chen, Hua-Jun, Sun, Yue-Li, Zhou, Qing, Yang, Jin-Ji, Yang, Xue-Ning, Lin, Jia-Xin, Yan, Hong-Hong, Zhai, Hao-Ran, Yan, Li-Xu, Liao, Ri-Qiang, Wu, Si-Pei, Wu, Yi-Long

“…Although clinical studies have shown promise for targeting programmed cell death protein-1 (PD-1) and ligand (PD-L1) signaling in non-small cell lung cancer…”
Get full text

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients by Zhang, Xu-Chao, Wang, Jun, Shao, Guo-Guang, Wang, Qun, Qu, Xiaotao, Wang, Bo, Moy, Christopher, Fan, Yue, Albertyn, Zayed, Huang, Xiayu, Zhang, Jingyu, Qiu, Yang, Platero, Suso, Lorenzi, Matthew V., Zudaire, Enrique, Yang, Jennifer, Cheng, Ying, Xu, Lin, Wu, Yi-Long

“…Deep understanding of the genomic and immunological differences between Chinese and Western lung cancer patients is of great importance for target therapy…”
Get full text